| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Nakao Iwat. Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials. Neuropsychiatric disease and treatment. vol 11. 2015-03-11. PMID:25759585. |
aripiprazole for the management of schizophrenia in the japanese population: a systematic review and meta-analysis of randomized controlled trials. |
2015-03-11 |
2023-08-13 |
Not clear |
| Taro Kishi, Yuki Matsuda, Shinji Matsunaga, Nakao Iwat. Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials. Neuropsychiatric disease and treatment. vol 11. 2015-03-11. PMID:25759585. |
we conducted a systematic review and meta-analysis of randomized controlled trials comparing aripiprazole with pooled antipsychotics in japanese patients with schizophrenia. |
2015-03-11 |
2023-08-13 |
Not clear |
| Huafang Li, Jianfeng Luo, Chuanyue Wang, Shiping Xie, Xiufeng Xu, Xiaoping Wang, Wenjuan Yu, Niufan Gu, John M Kan. Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24994555. |
efficacy and safety of aripiprazole in chinese han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial. |
2015-02-26 |
2023-08-13 |
human |
| Huafang Li, Jianfeng Luo, Chuanyue Wang, Shiping Xie, Xiufeng Xu, Xiaoping Wang, Wenjuan Yu, Niufan Gu, John M Kan. Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24994555. |
antipsychotics, such as aripiprazole and risperidone, are often used to treat individuals with schizophrenia. |
2015-02-26 |
2023-08-13 |
human |
| Huafang Li, Jianfeng Luo, Chuanyue Wang, Shiping Xie, Xiufeng Xu, Xiaoping Wang, Wenjuan Yu, Niufan Gu, John M Kan. Efficacy and safety of aripiprazole in Chinese Han schizophrenia subjects: a randomized, double-blind, active parallel-controlled, multicenter clinical trial. Schizophrenia research. vol 157. issue 1-3. 2015-02-26. PMID:24994555. |
the objective of this study is to investigate the efficacy, safety, and tolerability of aripiprazole and risperidone in chinese han schizophrenia subjects in mainland china. |
2015-02-26 |
2023-08-13 |
human |
| Chan-Hen Tsai, Tzu-Ting Chen, Wei-Lieh Huan. Combination of escitalopram and aripiprazole causes significant improvement of negative symptoms of simple schizophrenia. Psychiatry and clinical neurosciences. vol 68. issue 7. 2015-02-21. PMID:24521035. |
combination of escitalopram and aripiprazole causes significant improvement of negative symptoms of simple schizophrenia. |
2015-02-21 |
2023-08-12 |
Not clear |
| Chris A Oosterhof, Mostafa El Mansari, Pierre Blie. Acute effects of brexpiprazole on serotonin, dopamine, and norepinephrine systems: an in vivo electrophysiologic characterization. The Journal of pharmacology and experimental therapeutics. vol 351. issue 3. 2015-02-17. PMID:25225185. |
brexpiprazole, a compound sharing structural molecular characteristics with aripiprazole, is currently under investigation for the treatment of schizophrenia and depression. |
2015-02-17 |
2023-08-13 |
Not clear |
| John M Kane, Timothy Peters-Strickland, Ross A Baker, Peter Hertel, Anna Eramo, Na Jin, Pamela P Perry, Michelle Gara, Robert D McQuade, William H Carson, Raymond Sanche. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry. vol 75. issue 11. 2015-02-09. PMID:25188501. |
aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study. |
2015-02-09 |
2023-08-13 |
Not clear |
| John M Kane, Timothy Peters-Strickland, Ross A Baker, Peter Hertel, Anna Eramo, Na Jin, Pamela P Perry, Michelle Gara, Robert D McQuade, William H Carson, Raymond Sanche. Aripiprazole once-monthly in the acute treatment of schizophrenia: findings from a 12-week, randomized, double-blind, placebo-controlled study. The Journal of clinical psychiatry. vol 75. issue 11. 2015-02-09. PMID:25188501. |
to evaluate aripiprazole once-monthly (aom), a long-acting injectable suspension of aripiprazole, as acute treatment in patients with schizophrenia (dsm-iv-tr). |
2015-02-09 |
2023-08-13 |
Not clear |
| Stephan Here. Long-acting injectable antipsychotics: an underutilized treatment option. The Journal of clinical psychiatry. vol 75. issue 11. 2015-02-09. PMID:25470087. |
in this issue, kane and colleagues report on the efficacy of aripiprazole long-acting injection (lai) in the treatment of an acute episode of schizophrenia. |
2015-02-09 |
2023-08-13 |
Not clear |
| Stephan Here. Long-acting injectable antipsychotics: an underutilized treatment option. The Journal of clinical psychiatry. vol 75. issue 11. 2015-02-09. PMID:25470087. |
the outcomes suggest that aripiprazole long-acting is a viable treatment option for patients experiencing an acute episode of schizophrenia. |
2015-02-09 |
2023-08-13 |
Not clear |
| Taro Kunitomi, Masayuki Hashiguchi, Mayumi Mochizuk. Indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia. British journal of clinical pharmacology. vol 77. issue 5. 2015-02-07. PMID:23919914. |
indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia. |
2015-02-07 |
2023-08-12 |
Not clear |
| Taro Kunitomi, Masayuki Hashiguchi, Mayumi Mochizuk. Indirect comparison analysis of efficacy and safety between olanzapine and aripiprazole for schizophrenia. British journal of clinical pharmacology. vol 77. issue 5. 2015-02-07. PMID:23919914. |
indirect comparison (ic) and direct comparison (dc) between aripiprazole and olanzapine for schizophrenia were conducted to compare their efficacy and safety. |
2015-02-07 |
2023-08-12 |
Not clear |
| Shufen Zhang, Guanghua La. Prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia. Shanghai archives of psychiatry. vol 26. issue 6. 2015-02-02. PMID:25642108. |
prospective 8-week trial on the effect of olanzapine, quetiapine, and aripiprazole on blood glucose and lipids among individuals with first-onset schizophrenia. |
2015-02-02 |
2023-08-13 |
Not clear |
| Rachel Hershenberg, Daniel F Gros, Olga Brawman-Mintze. Role of atypical antipsychotics in the treatment of generalized anxiety disorder. CNS drugs. vol 28. issue 6. 2015-01-22. PMID:24794100. |
atypical antipsychotics such as quetiapine, aripiprazole, olanzapine, and risperidone have been shown to be helpful in addressing a range of anxiety and depressive symptoms in individuals with schizophrenia and schizoaffective disorders, and have since been used in the treatment of a range of mood and anxiety disorders. |
2015-01-22 |
2023-08-13 |
human |
| Yasuhiro Matsuda, Sayaka Sato, Kazuhiko Iwata, Shunichi Furukawa, Norifumi Hatsuse, Yukako Watanabe, Nobuo Anzai, Toshifumi Kishimoto, Emi Ikebuch. Effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia. Psychiatry and clinical neurosciences. vol 68. issue 6. 2015-01-20. PMID:24506576. |
effects of risperidone and aripiprazole on neurocognitive rehabilitation for schizophrenia. |
2015-01-20 |
2023-08-12 |
Not clear |
| David H Adams, Bruce J Kinon, Simin Baygani, Brian A Millen, Isabella Velona, Sara Kollack-Walker, David P Wallin. A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia. BMC psychiatry. vol 13. 2015-01-06. PMID:23694720. |
we compared the time to discontinuation due to lack of tolerability over 24 weeks in patients suffering from schizophrenia treated with pomaglumetad methionil (ly2140023 monohydrate, the prodrug of metabotropic glutamate 2/3 receptor agonist, ly404039) or standard of care (soc: olanzapine, risperidone, or aripiprazole). |
2015-01-06 |
2023-08-12 |
Not clear |
| Alessia Luoni, Fabio Fumagalli, Giorgio Racagni, Marco A Riv. Repeated aripiprazole treatment regulates Bdnf, Arc and Npas4 expression under basal condition as well as after an acute swim stress in the rat brain. Pharmacological research. vol 80. 2015-01-06. PMID:24309096. |
overall, our results provide novel information regarding the mechanisms through which aripiprazole may regulate brain function and could contribute to improve neuroplastic defects that are associated with schizophrenia symptomatology. |
2015-01-06 |
2023-08-12 |
rat |
| Daniel Umbricht, Richard S E Keefe, Stephen Murray, David A Lowe, Richard Porter, George Garibaldi, Luca Santarell. A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. vol 39. issue 7. 2014-12-29. PMID:24549101. |
this 8-week (week 1, inpatient; weeks 2-8, outpatient), double-blind, randomized study used measurement and treatment research to improve cognition in schizophrenia (matrics) guidelines to investigate the nicotinic α7 partial agonist rg3487 (formerly mem3454) in cias; 215 patients with chronic stable schizophrenia received placebo or rg3487 (5, 15, or 50 mg) added to ongoing treatment with risperidone, paliperidone, or aripiprazole. |
2014-12-29 |
2023-08-12 |
Not clear |
| Hikaru Hori, Jun Nakamur. Hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia. Clinical neuropharmacology. vol 37. issue 3. 2014-12-23. PMID:24824665. |
hiccups associated with switching from olanzapine to aripiprazole in a patient with paranoid schizophrenia. |
2014-12-23 |
2023-08-13 |
Not clear |